Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,410 | -1,310 | -2,190 | -3,190 | -3,670 |
| Depreciation Amortization | 10 | 20 | 80 | 170 | 130 |
| Other Working Capital | 820 | 810 | 1,080 | 1,330 | 670 |
| Other Operating Activity | 870 | 780 | 860 | 380 | 730 |
| Operating Cash Flow | $290 | $300 | $-170 | $-1,310 | $-2,140 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | 0 | -210 | -60 |
| Net Acquisitions | 0 | 0 | 0 | 0 | -250 |
| Other Investing Activity | -370 | -190 | -10 | 80 | -220 |
| Investing Cash Flow | $-370 | $-190 | $-10 | $-130 | $-530 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 20 | -250 | 1,550 | 2,920 |
| Financing Cash Flow | $0 | $20 | $-250 | $1,550 | $2,920 |
| Beginning Cash Position | 200 | 60 | 490 | 390 | 140 |
| End Cash Position | 110 | 200 | 60 | 490 | 390 |
| Net Cash Flow | $-80 | $140 | $-430 | $100 | $250 |
| Free Cash Flow | |||||
| Operating Cash Flow | 290 | 300 | -170 | -1,310 | -2,140 |
| Free Cash Flow | 290 | 300 | -170 | -1,310 | -2,140 |